Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€450.00
-25.76%
11.12.20
11.12.20
Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Citizens Financial
Start price
Target price
Perf. (%)
€27.20
21.11.20
21.11.20
-
21.11.21
21.11.21
15.44%
22.01.21
22.01.21
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Apple Inc.
Start price
Target price
Perf. (%)
€99.28
20.11.20
20.11.20
€130.00
20.11.21
20.11.21
25.18%
21.07.21
21.07.21
Could be very worthwhile Investment >20% year
Teleflex Inc.
Start price
Target price
Perf. (%)
€308.00
20.11.20
20.11.20
-
20.11.21
20.11.21
8.44%
14.02.21
14.02.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€437.60
19.11.20
19.11.20
€426.00
19.11.21
19.11.21
1.19%
23.11.20
23.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.40
18.11.20
18.11.20
-
18.11.21
18.11.21
45.06%
19.11.21
19.11.21
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
Amazon.com Inc.
Start price
Target price
Perf. (%)
€133.58
16.11.20
16.11.20
-
16.11.21
16.11.21
0.24%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
American Water Works Corp. Inc.
Start price
Target price
Perf. (%)
€138.12
14.11.20
14.11.20
€155.00
14.11.21
14.11.21
10.30%
06.08.21
06.08.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.30
14.11.20
14.11.20
-
14.11.21
14.11.21
-1.75%
23.11.20
23.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Verisk Analytics A
Start price
Target price
Perf. (%)
€174.02
13.11.20
13.11.20
-
13.11.21
13.11.21
-9.85%
13.02.21
13.02.21
EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very low/no dividend yield expected
International Business Machines Corp
Start price
Target price
Perf. (%)
€98.48
13.11.20
13.11.20
€118.00
13.11.21
13.11.21
5.71%
14.11.21
14.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
International Business Machines Corp
Start price
Target price
Perf. (%)
€98.00
13.11.20
13.11.20
-
13.11.21
13.11.21
26.48%
10.06.21
10.06.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.60
13.11.20
13.11.20
€52.00
1.38%
14.11.20
14.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Apple Inc.
Start price
Target price
Perf. (%)
€101.48
13.11.20
13.11.20
€110.00
3.84%
16.12.20
16.12.20
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€106.88
12.11.20
12.11.20
€110.00
4.79%
14.11.20
14.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Truist Financial Corp.
Start price
Target price
Perf. (%)
€41.60
11.11.20
11.11.20
-
11.11.21
11.11.21
5.29%
14.01.21
14.01.21
Very high dividend yield expected
Probably not worthwhile Investment
Business model of the past or high risk
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.00
09.11.20
09.11.20
€55.00
2.66%
10.11.20
10.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.30
09.11.20
09.11.20
€37.95
-11.94%
17.12.20
17.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio